日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/12/14 | 8,100 | 8,210 | 8,080 | 8,090 | ±0 | ±0% | 134,700 |
| 2021/12/13 | 8,210 | 8,240 | 8,080 | 8,090 | +10 | +0.1% | 109,100 |
| 2021/12/10 | 8,200 | 8,210 | 8,060 | 8,080 | -130 | -1.6% | 137,400 |
| 2021/12/09 | 8,260 | 8,340 | 8,210 | 8,210 | -200 | -2.4% | 97,300 |
| 2021/12/08 | 8,500 | 8,560 | 8,380 | 8,410 | +60 | +0.7% | 183,900 |
| 2021/12/07 | 8,130 | 8,380 | 8,080 | 8,350 | +200 | +2.5% | 130,500 |
| 2021/12/06 | 8,210 | 8,300 | 8,140 | 8,150 | -70 | -0.9% | 104,500 |
| 2021/12/03 | 8,130 | 8,220 | 8,040 | 8,220 | +60 | +0.7% | 170,700 |
| 2021/12/02 | 8,190 | 8,260 | 8,160 | 8,160 | -70 | -0.9% | 174,100 |
| 2021/12/01 | 8,360 | 8,390 | 8,160 | 8,230 | -170 | -2% | 245,500 |
| 2021/11/30 | 8,520 | 8,660 | 8,400 | 8,400 | -120 | -1.4% | 467,500 |
| 2021/11/29 | 8,620 | 8,690 | 8,490 | 8,520 | -90 | -1% | 161,500 |
| 2021/11/26 | 8,810 | 8,860 | 8,540 | 8,610 | -200 | -2.3% | 124,400 |
| 2021/11/25 | 8,770 | 8,920 | 8,710 | 8,810 | +110 | +1.3% | 110,900 |
| 2021/11/24 | 8,650 | 8,720 | 8,590 | 8,700 | -60 | -0.7% | 110,800 |
| 2021/11/22 | 8,620 | 8,800 | 8,600 | 8,760 | +140 | +1.6% | 96,100 |
| 2021/11/19 | 8,720 | 8,730 | 8,560 | 8,620 | -50 | -0.6% | 119,700 |
| 2021/11/18 | 8,750 | 8,790 | 8,600 | 8,670 | -160 | -1.8% | 85,700 |
| 2021/11/17 | 9,010 | 9,090 | 8,800 | 8,830 | -150 | -1.7% | 82,900 |
| 2021/11/16 | 8,750 | 9,020 | 8,750 | 8,980 | +110 | +1.2% | 146,100 |
| 2021/11/15 | 8,900 | 8,900 | 8,720 | 8,870 | +50 | +0.6% | 150,900 |
| 2021/11/12 | 8,620 | 8,880 | 8,580 | 8,820 | +200 | +2.3% | 175,300 |
| 2021/11/11 | 8,920 | 8,920 | 8,550 | 8,620 | -330 | -3.7% | 205,400 |
| 2021/11/10 | 9,020 | 9,040 | 8,930 | 8,950 | -80 | -0.9% | 87,400 |
| 2021/11/09 | 9,090 | 9,100 | 8,970 | 9,030 | -30 | -0.3% | 88,400 |
| 2021/11/08 | 9,320 | 9,320 | 9,040 | 9,060 | -300 | -3.2% | 106,900 |
| 2021/11/05 | 9,270 | 9,360 | 9,210 | 9,360 | ±0 | ±0% | 83,000 |
| 2021/11/04 | 9,450 | 9,470 | 9,300 | 9,360 | +150 | +1.6% | 180,400 |
| 2021/11/02 | 9,230 | 9,280 | 9,200 | 9,210 | -110 | -1.2% | 85,700 |
| 2021/11/01 | 9,280 | 9,330 | 9,200 | 9,320 | +210 | +2.3% | 100,600 |
| 2021/10/29 | 9,020 | 9,150 | 8,940 | 9,110 | +90 | +1% | 169,800 |
| 2021/10/28 | 9,170 | 9,180 | 8,970 | 9,020 | -120 | -1.3% | 603,500 |
| 2021/10/27 | 9,020 | 9,140 | 8,990 | 9,140 | +90 | +1% | 149,100 |
| 2021/10/26 | 8,990 | 9,070 | 8,910 | 9,050 | +130 | +1.5% | 193,500 |
| 2021/10/25 | 8,840 | 9,020 | 8,820 | 8,920 | -20 | -0.2% | 150,800 |
| 2021/10/22 | 8,910 | 9,100 | 8,910 | 8,940 | -30 | -0.3% | 160,300 |
| 2021/10/21 | 8,880 | 9,040 | 8,850 | 8,970 | +60 | +0.7% | 145,400 |
| 2021/10/20 | 8,940 | 8,940 | 8,800 | 8,910 | +100 | +1.1% | 159,400 |
| 2021/10/19 | 8,840 | 8,900 | 8,750 | 8,810 | -120 | -1.3% | 136,700 |
| 2021/10/18 | 9,110 | 9,130 | 8,850 | 8,930 | -270 | -2.9% | 136,200 |
| 2021/10/15 | 8,990 | 9,230 | 8,880 | 9,200 | +340 | +3.8% | 179,000 |
| 2021/10/14 | 8,710 | 8,860 | 8,640 | 8,860 | +20 | +0.2% | 144,700 |
| 2021/10/13 | 8,810 | 8,880 | 8,730 | 8,840 | +10 | +0.1% | 122,500 |
| 2021/10/12 | 8,780 | 8,910 | 8,780 | 8,830 | +10 | +0.1% | 222,000 |
| 2021/10/11 | 8,660 | 8,850 | 8,620 | 8,820 | +40 | +0.5% | 91,700 |
| 2021/10/08 | 8,660 | 8,860 | 8,620 | 8,780 | +150 | +1.7% | 135,800 |
| 2021/10/07 | 8,670 | 8,720 | 8,600 | 8,630 | -20 | -0.2% | 141,400 |
| 2021/10/06 | 8,790 | 8,860 | 8,610 | 8,650 | -210 | -2.4% | 173,100 |
| 2021/10/05 | 9,030 | 9,080 | 8,830 | 8,860 | -320 | -3.5% | 118,900 |
| 2021/10/04 | 9,210 | 9,220 | 9,060 | 9,180 | +60 | +0.7% | 88,400 |
851～
900
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
